制药和生物制药

计算机仿真药物制造和输送

制药和生物制药行业领导者正在利用计算机仿真的力量来解决开发药物制造、扩大生产规模和药物输送流程所需的不可持续成本和时间问题。

Learn How

Digitally Transforming Drug Manufacturing and Delivery

The drug manufacturing process - from discovery to mass production - is a lengthy and costly endeavor. Ansys, part of Synopsys, provides the in silico technologies, such as computational modeling and simulation (CM&S), artificial intelligence (AI), and digital twins, to optimize and speed up the process safely. Validated, multiphysics models of manufacturing processes, drug-delivery mechanisms, and more ensure innovators create safe and effective pharmaceuticals.

Lower Costs with Better, Safer Processes

Streamlined Scaling Processes

Engineering simulation streamlines scale-up and optimizes upstream and downstream operations, reducing development time and operating costs.

Learn More

Homogeneous Mixing

Whether small or large molecules, fluids, or powders, mixing simulations model the process of blending one or more materials in mixing tanks or bioreactors.

Learn More

In Silico Clinical Trials

Applying validated computer models of medical devices to hundreds or thousands of virtual patients provides complementary evidence of product performance for a more robust regulatory approval submission.

Learn More

Applications

Simulation provides a transformative approach that minimizes development risks and expenses across various health applications. With virtual testing, manufacturers can identify design flaws early, reducing reliance on costly physical prototypes and extensive testing phases.

混合

Ansys流体混合仿真工具可帮助您对多相混合过程，以及一种或多种流体类材料的混合进行建模。

了解更多

The Rise of In Silico Medicine

Below is a curated list of success stories and thought leadership from our colleagues, customers, and partners around the world using simulation to advance healthcare.

At the Forefront of Drug Innovation With Pfizer

Learn how Pfizer uses simulation to deliver medicines to people faster, such as by reducing clinical trial times, manufacturing, and time to market.

Learn More

Sartorius Finds That Simulation Is the Perfect Prescription

See how Sartorius, which supports drug discovery efforts of biopharmaceutical companies, relies on simulation to drive rapid, cost-effective product development.

Learn More

Simulation Helps GSK Bring Critical Medicines to Patients Faster

Learn how GSK optimized bioreactor scaling with Ansys fluid simulations and digital twins.

Learn More

Accelerating drug development with casual AI and digital twins Ansys and Nova in silico partner for ISCT solution

Accelerating Drug Development with Causal AI & Digital Twins: Ansys and Nova In Silico Partner for ISCT Solution

Learn how Ansys simulation improves lyophilization by optimizing heat/mass transfer, sublimation, and equipment design for faster, more efficient pharma production.

Learn More

医疗行业的变革就此开始：您准备好了吗？

计算机仿真医学有望从根本上重塑医疗行业，同时增加创新并降低成本。

医疗行业的仿真可带来超过500%的投资回报。

获得良好的医疗服务应当是每个人的基本权利。然而，事实证明，确立和维护这项权利对一些经济体来说是一项重大的挑战。

查看白皮书

为世界各地的不同人群提供高质量的医疗服务是一项极具挑战性的工作。医疗支出正在迅速增长，产品安全法规比以往任何时候都更加严格。随着世界人口的增长，开发合适的药物并使其易于获得将成为一项更加艰巨的任务。

传统模式下的药物开发和输送无法满足对快速原型制作不断增长的需求，同时不会给制造商带来不可持续的成本。通过进行快速原型制作以及快速、广泛的测试来满足监管要求，仿真有望大规模颠覆医疗行业。通过将生产和实际测试严格限制在必要的范围内，工程仿真使得在合理的预算下开发新药物成为可能，从而为世界提供安全、有用的药物，并为积极采取行动的公司带来丰厚回报。